|
Given Imaging (Hebrew: גיוון אימג'ינג) is an Israeli medical technology company that manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. It is dual-listed on both the NASDAQ and the Tel Aviv Stock Exchange, where it is a component of the TA-100 Index and the TA BlueTech-50 Index. Given Imaging pioneered the capsule endoscopy technology and has also developed capsule-based pH monitoring.〔(Invest in Israel: Given Imaging )〕 Through Sierra Scientific Instruments, a subsidiary, Given Imaging also provides an array of diagnostic modalities including high-resolution manometry and ambulatory reflux monitoring. Given Imaging's technology is currently marketed in over 60 countries. == History == Given Imaging was founded in 1998 by Dr. Gabi Iddan and Dr. Gavriel Meron, initial funding for the company was provided by Elron Electronic Industries, Israel's leading technology holding company, in cooperation with Rafael Advanced Defense Systems. Today Elron still holds 28% Given Imaging's shares.〔(Elron Announces That Given Imaging, Held Directly and Indirectly 15% by Elron, Announced Initial Public Offering. Business Wire, October 4, 2001 )〕 The idea for the solution was developed by Dr. Iddan, while working in the missile division of Rafael, where he envisioned that missile technology could be miniaturized to create a medical product.〔(RDC – Rafael Development Corporation Ltd - Given Imaging Copnay History )〕 The company's first capsule endoscopy products was named M2A capsule and received it CE marking in May 2001 and in August 2011 was cleared by the US Food and Drug Administration (FDA) for visualization of abnormalities of the small intestine〔(Athena: Clinical Policy Bulletin: Capsule Endoscopy )〕 The capsule uses a radio developed for Given by Zarlink Semiconductor's medical team in San Diego and Jarfalla, Sweden. In October 2001, Given Imaging had an Initial public offering on NASDAQ under ticker GIVN.)〔(Given Imaging: First IPO since August IPO Report - MarketWatch - 4 Oct 2001 )〕 In September 2004, M2A capsule re-branded PillCam SB(R). In March 2004, Given Imaging became a member of the Tel Aviv Stock Exchange〔(Given Imaging Registration Document March 22, 2004 )〕 In November 2004, US FDA clears PillCam(R) ESO for the esophagus In May 2006, US FDA clears Agile Patency System〔(Given Imaging's Agile(TM) Patency System Receives US Marketing Clearance, Medical News Today, 17 May 2006 )〕 In October 2006, PillCam COLON was cleared for marketing in the European Union (CE Mark)〔(Pillcam(R) COLON May Be A Cost-Effective Strategy For Preventing Colo-Rectal Cancer, Study, Medical News Today 11 Apr 2008 )〕 In May 2007, Second-generation PillCam SB 2 received U.S. marketing clearance and in June 2007, Second-generation PillCam ESO 2 received U.S. marketing clearance In December 2008, Given Imaging acquired Bravo pH Monitoring System(R) In May 2009, 1 millionth PillCam capsule was sold〔(Given Imaging Announces One Millionth PillCam Video Capsule, Marketwire May 20, 2009 )〕 In September 2009, PillCam COLON 2 receives CE Mark〔(Given Imaging'c PillCam COLON 2 video capsule and system receives the CE mark for sale in Europe, The Mdeical News, 14. September )〕 In April 2010, Given Imaging acquired Sierra Scientific Instruments In July 2012, Given Imaging's capsule endoscopy featured in a live broadcast on the BBC, when the reporter Michael Mosley spent the day as an exhibit at the Science Museum in London, after swallowing a PillCam which transmitted live pictures to a public screen.〔(The second brain in our stomachs ), 12 July 2012, Michael Mosley, BBC〕 In February 2014, 100% of Given Imaging's shares were purchased by Covidien, making it a Private Company fully owned by Covidien. As a result, its shares are no longer traded neither in NASDAQ nor in TASE〔(Announcement Regarding Completion of Merging with Covidien )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Given Imaging」の詳細全文を読む スポンサード リンク
|